W
IBB icon

WealthShield’s iShares Biotechnology ETF IBB Stock Holding History

WealthShield’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$23K Buy
+207
New +$22.1K 0.01% 173

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WealthShield's IBB Position: Q4 2017 in Review

WealthShield opened a new position in iShares Biotechnology ETF (IBB) in Q4 2017: 207 shares worth $23K. The stake represents 0.01% of the portfolio and ranks #173 among its holdings.

624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • WealthShield held 207 shares of iShares Biotechnology ETF worth $23K as of Q4 2017.
  • iShares Biotechnology ETF was a new WealthShield position in Q4 2017.
  • iShares Biotechnology ETF made up 0.01% of WealthShield's portfolio in Q4 2017, its #173 holding.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on WealthShield's 13F filing for Q4 2017, filed 14 Feb 2018.